The Ethics of Genetic Commerce
1st Edition
Will be published approx. on 24. August 2007
Book
Hardback
240 pages
978-1-4051-6698-0 (ISBN)
Description
Our rapidly expanding genetic knowledge today points toward a near future in which the elements of humanity closest to our moral core may themselves be produced, manipulated, commodified, and exchanged.
Explores the moral and ethical concerns derived from an increasing knowledge of genetics and the variety of its commercial applications
A major contribution to the emerging understanding of the role that ethics will play in genetic commerce
Written by experts from the academic and corporate sector, with diverse backgrounds in business, social science, and philosophy
Addresses a range of relevant issues, including genetic screening, the use of individual's genetic information, the rise of genetically modified foods, patenting, pharmaceutical mergers and monopolization, and the implications of genetic testing on non-human mammals
Explores the moral and ethical concerns derived from an increasing knowledge of genetics and the variety of its commercial applications
A major contribution to the emerging understanding of the role that ethics will play in genetic commerce
Written by experts from the academic and corporate sector, with diverse backgrounds in business, social science, and philosophy
Addresses a range of relevant issues, including genetic screening, the use of individual's genetic information, the rise of genetically modified foods, patenting, pharmaceutical mergers and monopolization, and the implications of genetic testing on non-human mammals
Reviews / Votes
"These essays demonstrate the critical importance of applied ethics as we all grapple with the biotechnology revolution. These scholars use ethics to illustrate the conflicts that emerge from commercializing genetic technologies and to indicate how moral reasoning could help society make better decisions about how to deploy them. A much needed contribution to understanding the expanding role of genetic technologies in our world."Keith Douglass Warner, Santa Clara University
More details
Language
English
Place of publication
Hoboken
United Kingdom
Publishing group
John Wiley and Sons Ltd
Target group
Professional and scholarly
Product notice
sewn/stitched
Paper over boards
Dimensions
Height: 235 mm
Width: 186 mm
Thickness: 24 mm
Weight
259 gr
ISBN-13
978-1-4051-6698-0 (9781405166980)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Robert Kolb
The Ethics of Genetic Commerce
E-Book
05/2008
Wiley-Blackwell
€50.99
Available for download
Person
Robert W. Kolb holds the Frank W. Considine Chair in Applied Ethics at Loyola University Chicago. He was formerly Assistant Dean for Business and Society (2003-2006) at the University of Colorado, and John S. and James L. Knight Professor of Finance at the University of Miami. He is author and co-author of numerous texts in finance, including Futures, Options, and Swaps, 5e (with James A. Overdahl, Blackwell, 2007) and Understanding Futures Markets, 6e (with James A. Overdahl, Blackwell, 2006).
Content
Preface. Part I: Genetic Screening.
1. Is a Genetics Screening Program for Job Applicants Ethical? An Analysis of the Conditions Necessary for Required Genetic Screenings in the Hiring Process (Thomas Harter).
2. The Business of Genetic Screening (Duane Windsor).
3. Genetic Commerce: The Challenges for Human Resource Management (Karen S. Markel and Lizabeth A. Barclay).
4. Geneticize Me! The Case for Direct-to-Consumer Genetic Testing (Ronald Munson).
5. Proscription, Prescription, or Market Process? Comments on Genetic Screening (Eugene Heath).
Part II: Genetically Modified Foods.
6. Transgenic Organisms, the European Union, and the World Trade Organization(Dennis Cooley).
7. Commercialization of the Agrarian Ideal and Arguments against the New "Green Revolution: Feeding the World with "Frankenfoods"? (Johann A. Klaasen).
8. Corporate Decisions about GM Food Labeling (Chris MacDonald and Melissa Whellams).
9. Moral Imagination, Stakeholder Engagement, and Genetically Modified Organisms (Denis Arnold).
Part III: Corporate Governance and Genetic Commerce.
10. Who Owns My Ideas About Your Body? (Asher Meir).
11. Pharmaceutical Mergers and Genetic Technology: A Problematic Combination (Michael Potts).
12. Stakeholder Care Theory: The Case of Genetic Engineering (Jamie R. Hendry).
13. Unresolved Issues and Further Questions: Meir, Potts and Hendry (Laura Hartman)
1. Is a Genetics Screening Program for Job Applicants Ethical? An Analysis of the Conditions Necessary for Required Genetic Screenings in the Hiring Process (Thomas Harter).
2. The Business of Genetic Screening (Duane Windsor).
3. Genetic Commerce: The Challenges for Human Resource Management (Karen S. Markel and Lizabeth A. Barclay).
4. Geneticize Me! The Case for Direct-to-Consumer Genetic Testing (Ronald Munson).
5. Proscription, Prescription, or Market Process? Comments on Genetic Screening (Eugene Heath).
Part II: Genetically Modified Foods.
6. Transgenic Organisms, the European Union, and the World Trade Organization(Dennis Cooley).
7. Commercialization of the Agrarian Ideal and Arguments against the New "Green Revolution: Feeding the World with "Frankenfoods"? (Johann A. Klaasen).
8. Corporate Decisions about GM Food Labeling (Chris MacDonald and Melissa Whellams).
9. Moral Imagination, Stakeholder Engagement, and Genetically Modified Organisms (Denis Arnold).
Part III: Corporate Governance and Genetic Commerce.
10. Who Owns My Ideas About Your Body? (Asher Meir).
11. Pharmaceutical Mergers and Genetic Technology: A Problematic Combination (Michael Potts).
12. Stakeholder Care Theory: The Case of Genetic Engineering (Jamie R. Hendry).
13. Unresolved Issues and Further Questions: Meir, Potts and Hendry (Laura Hartman)